Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 4
1986 2
1987 1
1988 1
1989 2
1990 1
1991 3
1993 1
1994 3
1995 1
1997 1
2000 1
2004 2
2005 4
2006 1
2009 1
2010 1
2011 3
2012 7
2013 5
2014 5
2015 7
2016 6
2017 8
2018 12
2019 8
2020 8
2021 6
2022 7
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
Corpechot C, Chazouillères O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, Goria O, Potier P, Minello A, Silvain C, Abergel A, Debette-Gratien M, Larrey D, Roux O, Bronowicki JP, Boursier J, de Ledinghen V, Heurgue-Berlot A, Nguyen-Khac E, Zoulim F, Ollivier-Hourmand I, Zarski JP, Nkontchou G, Lemoinne S, Humbert L, Rainteau D, Lefèvre G, de Chaisemartin L, Chollet-Martin S, Gaouar F, Admane FH, Simon T, Poupon R. Corpechot C, et al. Among authors: rainteau d. N Engl J Med. 2018 Jun 7;378(23):2171-2181. doi: 10.1056/NEJMoa1714519. N Engl J Med. 2018. PMID: 29874528 Free article. Clinical Trial.
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermúdez-Humarán LG, Pigneur B, Lequin O, Kharrat P, Thomas G, Rainteau D, Aubry C, Breyner N, Afonso C, Lavielle S, Grill JP, Chassaing G, Chatel JM, Trugnan G, Xavier R, Langella P, Sokol H, Seksik P. Quévrain E, et al. Among authors: rainteau d. Gut. 2016 Mar;65(3):415-425. doi: 10.1136/gutjnl-2014-307649. Epub 2015 Jun 4. Gut. 2016. PMID: 26045134 Free PMC article.
Protective potential of the gallbladder in primary sclerosing cholangitis.
Cazzagon N, Gonzalez-Sanchez E, El-Mourabit H, Wendum D, Rainteau D, Humbert L, Corpechot C, Chazouillères O, Arrivé L, Housset C, Lemoinne S. Cazzagon N, et al. Among authors: rainteau d. JHEP Rep. 2022 Dec 17;5(4):100649. doi: 10.1016/j.jhepr.2022.100649. eCollection 2023 Apr. JHEP Rep. 2022. PMID: 36923239 Free PMC article.
An obesogenic diet increases atherosclerosis through promoting microbiota dysbiosis-induced gut lymphocyte trafficking into the periphery.
Laurans L, Mouttoulingam N, Chajadine M, Lavelle A, Diedisheim M, Bacquer E, Creusot L, Suffee N, Esposito B, Melhem NJ, Le Goff W, Haddad Y, Paul JL, Rainteau D, Tedgui A, Ait-Oufella H, Zitvogel L, Sokol H, Taleb S. Laurans L, et al. Among authors: rainteau d. Cell Rep. 2023 Nov 28;42(11):113350. doi: 10.1016/j.celrep.2023.113350. Epub 2023 Oct 31. Cell Rep. 2023. PMID: 37897726 Free article.
Lipids in metabolic diseases.
Dugail I, Kalopissis A, Miquel M, Rainteau D, Zachowski A, Forest C. Dugail I, et al. Among authors: rainteau d. Biochimie. 2014 Jan;96:1-2. doi: 10.1016/j.biochi.2013.11.009. Biochimie. 2014. PMID: 24321080 No abstract available.
Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice.
Lallement J, Raho I, Merlen G, Rainteau D, Croyal M, Schiffano M, Kassis N, Doignon I, Soty M, Lachkar F, Krempf M, Van Hul M, Cani PD, Foufelle F, Amouyal C, Le Stunff H, Magnan C, Tordjmann T, Cruciani-Guglielmacci C. Lallement J, et al. Among authors: rainteau d. Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Aug;1868(8):159333. doi: 10.1016/j.bbalip.2023.159333. Epub 2023 May 22. Biochim Biophys Acta Mol Cell Biol Lipids. 2023. PMID: 37224999 Free article.
Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
Borup C, Vinter-Jensen L, Jørgensen SPG, Wildt S, Graff J, Gregersen T, Zaremba A, Borup Andersen T, Nøjgaard C, Timm HB, Rainteau D, Hansen SH, Rumessen JJ, Munck LK. Borup C, et al. Among authors: rainteau d. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):321-331. doi: 10.1016/S2468-1253(22)00401-0. Epub 2023 Feb 6. Lancet Gastroenterol Hepatol. 2023. PMID: 36758570 Clinical Trial.
Prospective comparison of diagnostic tests for bile acid diarrhoea.
Borup C, Vinter-Jensen L, Jørgensen SPG, Wildt S, Graff J, Gregersen T, Zaremba A, Andersen TB, Nøjgaard C, Timm HB, Lamazière A, Rainteau D, Hansen SH, Rumessen JJ, Munck LK. Borup C, et al. Among authors: rainteau d. Aliment Pharmacol Ther. 2024 Jan;59(1):39-50. doi: 10.1111/apt.17739. Epub 2023 Oct 5. Aliment Pharmacol Ther. 2024. PMID: 37794830 Clinical Trial.
103 results